Skip to main content
. 2019 May 7;6(4):701–710. doi: 10.1002/ehf2.12433

Table 1.

Characteristics of patients treated with extracorporeal membrane oxygenation in the three time cohorts and the total sample

Characteristics of ECMO‐treated patients in the three time cohorts (n = 74) 1988–2000
n = 10 (14%)
2001–12
n = 16 (22%)
2013–15
n = 48 (64%)
1988–2015
n=74 (100%)
Mean (SD) (range) or no (%) Mean (SD) (range) or no (%) Mean (SD) (range) or no (%) Mean (SD) (range) or no (%)
Age (years) 31 (21) (0–58) 48 (21) (0–73) 52 (16) (2–76) 48.6 (0–76)
Age < 18 2 (20) 1 (6) 2 (4) 5 (7)
Male 5 (50) 12 (75) 31 (65) 48 (65)
ECMO mode
VA 7 (70) 15 (94) 42 (87.5) 64 (86.5)
VV 3 (30) 1 (6) 6 (12.5) 10 (13.5)
Reason for support
Cardiac; all indications 2 (20) 12 (75) 29 (60) 43 (58)
Cardiogenic shock 0 8 18 26
Post‐cardiotomy 2 4 11 17
Pulmonary 5 (50) 1 (6) 7 (15) 13 (18)
E‐CPR 3 (30) 3 (19) 12 (25) 18 (24)
Bridge to transplant 0 3 (19) 3 (6) 6 (8)
Days ventilated pre‐ECMO 4 (10) (0–26) 0.25 (0.4) (0–1) 0.6 (1.5) (0–9) 0.9 (0–26)
Pre‐pH < 7.2 4 (40) 8 (50) 24 (50) 36 (49)
Cardiac arrest pre‐ECMO 3 (30) 6 (38) 27 (56) 36 (49)
Cannulation
Central/peripheral 2/4 (20/40) 1/11 (6/69) 4/39 (8/81) 7/54 (10/73)
Surgical/percutaneous 4/2 (40/20) 11/1 (69/6) 41/2 (86/4) 56/5 (76/7)
Not registered 4 (40) 4 (25) 5 (10) 13 (17)
Days on ECMO 6 (6) (1–21) 4.5 (3) (0.3–14) 6.6 (6) (0.3–21) 6 (0.3–21)
Days of hospital stay 15 (10) (5–29) 13 (10) (1–35) 21 (26) (1–125) 19 (1–125)
Discharged ongoing ECMO 0 2 (13) 6 (13) 8 (11)
Survived ECMO 6 (60) 8 (50) 28 (58) 42 (57)
Survived 30 days 5 (50) 7 (44) 22 (46) 34 (46)
Cardiac; all indications 0 5 (42) 13 (45) 18 (42)
Cardiogenic shock 0 3 (38) 11 (61) 14 (54)
Post‐cardiotomy 0 2 (50) 2 (19) 4 (24)
Pulmonary 3 (60) 1 (100) 4 (57) 8 (62)
E‐CPR 2 (67) 1 (33) 5 (42) 8 (44)
Survivors with neurological injury
Central 0 0 5 (23) 5 (15)
Peripheral 2 (40) 1 (14) 7 (32) 10 (29)

ECMO set‐up was defined by the last configuration used. The occurrence of neurological injuries in survivors is as described by discharge note information.